Discover insights into manufacturing and the Pharmacy 500 companies that shape the industry in the Pharmacy500 Platinum Pages 2026 publication!
Drug Shortage Mitigation refers to the strategies and processes implemented by healthcare providers, pharmacies, manufacturers, and regulatory agencies to prevent, manage, and alleviate the impact of drug shortages on patient care. A drug shortage occurs when the demand for a specific medication exceeds the supply, or when there are disruptions in manufacturing, distribution, or other factors that hinder the availability of the drug. Mitigation efforts focus on maintaining access to essential medications and minimizing the effects on treatment outcomes.
Effective mitigation strategies require a combination of proactive planning, alternative medication options, collaboration with regulatory agencies, and clear communication with healthcare providers and patients. By implementing these strategies, pharmacies and healthcare systems can minimize the impact of drug shortages and ensure that patient care is not compromised.
The Pharmacy500 is awarded to 500 pharmacy supply chain businesses and associations that significantly impacted dispensing pharmacies in the U.S. over the past year.
The following are complimentary benefits extended to Pharmacy500 companies and associations (coming this spring!)
Discover insights into manufacturing and the Pharmacy 500 companies that shape the industry in the Pharmacy500 Platinum Pages 2026 publication!
The 2026 Pharmacy500 Companies Market Teardown report provides a concise snapshot of the 2026 companies, highlighting new additions, examining regional distributions, practice settings, supply chain categories, and key conferences attended.
RXinsider’s Pharmacy500 Careers Outlook report identifies key employment trends and workforce dynamics across Pharmacy500 companies. Check out this report to learn more about open position trends and the current state of the job market impacting the pharmacy supply chain!
Fortune Magazine’s annual Fortune 500 ranks the largest U.S. companies by revenue. Many leaders in healthcare and pharmaceuticals drive medication production, distribution, and patient access. This report highlights their impact on the pharmacy industry.
Endo’s TruDelivery® RTU products remove the need for on-site compounding, dilution, or mixing. Their ready-to-use formulations reduce preparation time, minimize errors, and enhance efficiency while remaining easily accessible through wholesalers and GPO contracts. To learn more, visit the 20Ways Winter Hospital publication.
This report aims to educate Pharmacy500 professionals, pharmacy leaders, and industry stakeholders on the 503B compounding sector and its critical role in healthcare. 503B outsourcing facilities, regulated by the FDA, produce large quantities of sterile and non-sterile compounded medications to help address drug shortages and support clinical needs. By ensuring safety, compliance, and reliability, these facilities strengthen medication access and continuity of care across the healthcare system.
RXinsider’s Pharmacy500 Academy now offers training on pharmacy contract manufacturing and drug shortage mitigation, featuring product comparisons and company insights. Visit the Pharmacy500 Academy to learn more about pharmacy risk management.
AIS Healthcare
Amneal Pharmaceuticals LLC
Azurity Pharmaceuticals, Inc.
B. Braun Medical Inc.
Baxter
Central Admixture Pharmacy Services, Inc. (CAPS)
Cipla, Inc.
Civica
Dr. Reddy’s Laboratories Ltd.
Empower Pharmacy
Esco
Fagron
Fresenius Kabi Group
Germfree
Grifols
Hikma Pharmaceuticals
IsoTech Pharma
Leiters Health
LGM Pharma
McKesson Corporation
Medivant Healthcare
Moderna, Inc.
Nephron Pharmaceuticals Corporation
McKesson Corporation
OurPharma LLC
Par Health
Pine Pharmaceuticals
Precision Dose, Inc.
Quva
Revelation Pharma
SCA Pharma
STAQ Pharma, Inc.
Turbare Manufacturing
Wells Pharma
West Pharmaceutical Services, Inc.
YARAL Pharma Inc.
